124 related articles for article (PubMed ID: 38502397)
1. Using PBMCs in a Multiplex FluoroSpot Assay for Detection of Innate Immune Response-Modulating Impurities (IIRMIs).
Makower B; Ahlborg N
Methods Mol Biol; 2024; 2768():241-249. PubMed ID: 38502397
[TBL] [Abstract][Full Text] [Related]
2. Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.
Gimenes I; Caldeira C; Presgrave OA; de Moura WC; Villas Boas MH
Regul Toxicol Pharmacol; 2015 Oct; 73(1):356-60. PubMed ID: 26232706
[TBL] [Abstract][Full Text] [Related]
3. Soluble β-(1,3)-glucans enhance LPS-induced response in the monocyte activation test, but inhibit LPS-mediated febrile response in rabbits: Implications for pyrogenicity tests.
Pardo-Ruiz Z; Menéndez-Sardiñas DE; Pacios-Michelena A; Gabilondo-Ramírez T; Montero-Alejo V; Perdomo-Morales R
Eur J Pharm Sci; 2016 Jan; 81():18-26. PubMed ID: 26428698
[TBL] [Abstract][Full Text] [Related]
4. Development of a rabbit monocyte activation test as an alternative to the rabbit pyrogen test and its application in the analysis of plasma-derived products.
Kim JH; Jung K; Kim J; Lee J; Kim H; Song H; Han K; Park S; Ahn C; Kim CW
Biologicals; 2021 Jun; 71():20-30. PubMed ID: 33994086
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the Monocyte Activation Test (MAT) for hyperimmune sera in the routine of the quality control laboratory: Comparison with the Rabbit Pyrogen Test (RPT).
da Silva CC; Presgrave OA; Hartung T; de Moraes AM; Delgado IF
Toxicol In Vitro; 2016 Apr; 32():70-5. PubMed ID: 26688320
[TBL] [Abstract][Full Text] [Related]
6. An improved monocyte activation test using cryopreserved pooled human mononuclear cells.
Solati S; Aarden L; Zeerleder S; Wouters D
Innate Immun; 2015 Oct; 21(7):677-84. PubMed ID: 25907070
[TBL] [Abstract][Full Text] [Related]
7. Detection of innate immune response modulating impurities in therapeutic proteins.
Haile LA; Puig M; Kelley-Baker L; Verthelyi D
PLoS One; 2015; 10(4):e0125078. PubMed ID: 25901912
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the monocyte activation test for evaluating pyrogenicity of tick-borne encephalitis virus vaccine.
Etna MP; Giacomini E; Rizzo F; Severa M; Ricci D; Shaid S; Lambrigts D; Valentini S; Galli Stampino L; Alleri L; Gaggioli A; Von Hunolstein C; Spreitzer I; Coccia EM
ALTEX; 2020; 37(4):532-544. PubMed ID: 32488289
[TBL] [Abstract][Full Text] [Related]
9. Performance of monocyte activation test supplemented with human serum compared to fetal bovine serum.
Molenaar-de Backer MWA; Gitz E; Dieker M; Doodeman P; Ten Brinke A
ALTEX; 2021; 38(2):307-315. PubMed ID: 33118606
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
Valentini S; Santoro G; Baffetta F; Franceschi S; Paludi M; Brandini E; Gherardini L; Serruto D; Capecchi B
Vaccine; 2019 Jun; 37(29):3754-3760. PubMed ID: 30448065
[TBL] [Abstract][Full Text] [Related]
11. Validation of the monocyte activation test with three therapeutic monoclonal antibodies.
Daniels R; Van der Elst W; Dieltjens N; Appels T; So CK; Nys T; Voeten L; Breugelmans P; Molenaar-de Backer MWA; Gitz E; Poole S; Patel M
ALTEX; 2022; 39(4):621–635. PubMed ID: 35502618
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of human monocytes for pharmacopeial monocyte activation test.
Koryakina A; Frey E; Bruegger P
J Immunol Methods; 2014 Mar; 405():181-91. PubMed ID: 24456627
[TBL] [Abstract][Full Text] [Related]
13. A comparison of pyrogen detection tests in the quality control of meningococcal conjugate vaccines: The applicability of the Monocyte Activation Test.
Fernandes Silva V; da Silva Guedes Junior D; da Silveira IA; Santos Almeida A; de Paiva Conte F; Fernandes Delgado I; Caldeira Silva C; França Presgrave OA; Antunes de Mattos K
Altern Lab Anim; 2018 Nov; 46(5):255-272. PubMed ID: 30488711
[TBL] [Abstract][Full Text] [Related]
14. Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin.
Perdomo-Morales R; Pardo-Ruiz Z; Spreitzer I; Lagarto A; Montag T
ALTEX; 2011; 28(3):227-35. PubMed ID: 21993958
[TBL] [Abstract][Full Text] [Related]
15. Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test.
Borton LK; Coleman KP
ALTEX; 2018; 35(4):453-463. PubMed ID: 29901209
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test.
Nakagawa Y; Maeda H; Murai T
Clin Diagn Lab Immunol; 2002 May; 9(3):588-97. PubMed ID: 11986265
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pyrogen assays by testing products exhibiting low endotoxin recovery.
Thurman TL; Lahti CJ; Mateffy JM; Forng RY; von Wintzingerode F; Silva LM; Deutschmann SM; Mozier N
ALTEX; 2023; 40(1):117-124. PubMed ID: 35796330
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the human whole blood and human peripheral blood monocyte tests for pyrogens.
Andrade SS; Silveira RL; Schmidt CA; Júnior LB; Dalmora SL
Int J Pharm; 2003 Oct; 265(1-2):115-24. PubMed ID: 14522124
[TBL] [Abstract][Full Text] [Related]
19. Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.
Kikkert R; de Groot ER; Aarden LA
J Immunol Methods; 2008 Jul; 336(1):45-55. PubMed ID: 18456276
[TBL] [Abstract][Full Text] [Related]
20. The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens.
Solati S; Zhang T; Timman S
Innate Immun; 2022 Apr; 28(3-4):130-137. PubMed ID: 35491666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
